Genmab — Februar 2024
-
Ensayos Clínicos Activos | Fundación HM
Coordinamos ensayos clínicos en red para acelerar resultados y descubrimientos médicos. ¡Conoce nuestra labor!
Fundación HM (www.fundacionhm.com)
-
Major bank sees positive signals in Lundbeck's MSA study despite missed endpoint https://medwatch.com/News/Pharma___Biotech/article16812127.ece
-
Circio is testing TG01 mutant RAS cancer vaccine in combination with daratumumab and nivolumab in non-small cell lung cancer (NSCLC) https://www.circio.com/en/the-first-patient-has-been-dosed-in-circios-tg01-triple-combination-study/
-
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastisk Cervical Cancer https://www.proinvestor.com/investornyt/1111713/tisotumab-vedotin-marketing-authorization-application-validated-by-european-medicines-agency-for-treatment-of-recurrent-or-meta
-
Genmab: EMA vil behandle ansøgning om godkendelse af middel mod livmoderhalskræft https://www.proinvestor.com/investornyt/1111730/genmab-ema-vil-behandle-ansogning-om-godkendelse-af-middel-mod-livmoderhalskraeft
-
Abbvie reports Epkinly Q4 '23 US12 Intl 5 Total 17, Full year '23 : 26 / 5 / 31 . U.S. revenues reflect profit sharing. International revenues reflect product revenues as well as profit sharing from certain international territories. This compares to Q3 Genmab comment around $22 million in net sales for the quarter and $28 million year-to-date.
17
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind